Drug | ADA | CZP | ETN | GOL | IFX | IFX-dyyb | PBO |
---|---|---|---|---|---|---|---|
ADA | – | −0.4 (−1.1 to 0.3) | 0.08 (−0.4 to 0.6) | 0.1 (−0.4 to 0.7) | 0.08 (−0.6 to 0.8) | −0.1 (−1.1 to 0.9) | −1.5 (−1.8 to −1.1) |
CZP | 0.4 (−0.5 to 1.2) | – | 0.5 (−0.2 to 1.2) | 0.5 (−0.2 to 1.2) | 0.5 (−0.4 to 1.3) | 0.8 (−0.5 to 1.8) | −1 (−1.6 to −0.5) |
ETN | 0.00 (−0.6 to 0.5) | −0.4 (−1.1 to 0.4) | – | 0.03 (−0.5 to 0.5) | −0.00 (−0.7 to 0.6) | 0.4 (−0.7 to 1.3) | −1.5 (−1.8 to −1.3) |
GOL | −0.1 (−0.8 to 0.5) | −0.5 (−1.3 to 0.3) | −0.1 (−0.7 to 0.5) | – | −0.03 (−0.8 to 0.7) | 0.2 (−0.9 to 1.2) | −1.6 (−2 to −1.1) |
IFX | −0.6 (−1.2 to 0.1) | −1.0 (−1.7 to −0.03) | −0.6 (−1.1 to 0.05) | −0.4 (−1.1 to 0.4) | – | −0.2 (−1.0 to 0.6) | −1.5 (−2.1 to −1.0) |
IFX-dyyb | −0.4 (−1.4 to 0.7) | −0.3 (−1.3 to 0.8) | 0.2 (−0.7 to 1.1) | 0.2 (−0.7 to 1.2) | 0.2 (−0.5 to 0.9) | – | −1.3 (−2.2 to −0.4) |
PBO | 1.4 (1.0–1.8) | 1.1 (0.4–1.7) | 1.4 (1.1–1.8) | 1.6 (1.1–2.1) | 2 (1.4–2.5) | 1.8 (0.8–2.7) | – |